Photosensitivity increase

Photosensitivity increase is a clinical condition or adverse physiological response characterized by an abnormally heightened sensitivity of the skin to ultraviolet (UV) radiation or visible light. It is not a molecular target, such as a protein or receptor, but rather a phenotypic manifestation of underlying genetic, metabolic, or drug-induced factors. This condition is broadly categorized into phototoxicity—a dose-dependent, non-immunological reaction leading to cell damage—and photoallergy, which involves an immune-mediated hypersensitivity response. Numerous therapeutic agents, including tetracyclines, thiazide diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs), are known to increase photosensitivity by absorbing light energy and inducing oxidative stress or antigenic responses in the dermis and epidermis. Clinical management typically focuses on the identification of the offending agent, strict photoprotection, and treatment of the resulting dermatitis (StatPearls, 2023; NIH MedlinePlus, 2022).

Other names

PhotosensitivityDrug-induced photosensitivityPhototoxicityPhotoallergySun sensitivityAbnormal light sensitivity

Photosensitivity occurs through two primary mechanisms: phototoxicity and photoallergy. In phototoxicity, a drug or its metabolite absorbs ultraviolet (UV) or visible light energy, transitioning to an excited state that generates reactive oxygen species (ROS), causing direct damage to cellular membranes and DNA. In photoallergy, light energy transforms a drug into a hapten that binds to skin proteins, creating an antigen that triggers a delayed T-cell-mediated hypersensitivity reaction (StatPearls, 2023; PMC4870444).